Navigation Links
New Lawsuit Alleges Fosamax Increases Risk of Injury: Now, AttorneyOne Can Provide Advice
Date:1/7/2013

San Diego, CA (PRWEB) January 07, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Fosamax Side Effects lawsuits.

According to court documents, on November 15th, 2012, a St. Clair County woman filed a lawsuit in St. Clair County Circuit Court (case no. 12-L-616) alleging Fosamax makes exaggerated claims of its benefits. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. In the lawsuit plaintiff claims that Fosamax, instead of reducing the possibility of bone fractures, actually increases the risk of injury.

On October 31st, 2012, an Illinois woman and her husband filed a lawsuit in New Jersey District Court (case no. 3:2012cv06770) alleging she suffered a low energy femoral fracture from her use of osteoporosis drugs, Fosamax and Actonel.

Court documents indicate that as of December 22nd, 2012, more than 2,000 lawsuits were pending in the Fosamax Multicounty Litigation in New Jersey Superior Court (No. 282). Plaintiffs claim they suffer femur fractures, jaw problems or other injuries from taking the drug.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Fosamax severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Fosamax lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Results of the study published in June 25th, 2012, by the Journal of the American Medical Association Internal Medicine (formerly Archives of Internal Medicine), concluded that atypical femoral fractures were associated with bisphosphonate use; longer duration of treatment resulted in augmented risk.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/1/prweb10287016.htm.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10291723.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
2. “Nap Nanny” Deaths Grounds for Lawsuit
3. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
4. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
5. New Lawsuit on DePuy Hip Implants Metal Poisoning: Now, AttorneyOne Can Provide Advice
6. New Lawsuit on Avodart Prostate Cancer: Now, AttorneyOne Can Provide Advice
7. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
8. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
9. Warning Claim on Alleged Defective Wright Hip Implant Lawsuit Dismissed: AttorneyOne Informs
10. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
11. DrugRisk Announces Updated Information on Mirena Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: